Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 14601-14650 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04170283
Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies
PHASE3Active, not recruiting
955 participants
Started: Jan 16, 2020 · Completed: Dec 31, 2028
1 condition1 sponsor152 locations
NCT04233567
Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations
PHASE2Active, not recruiting
17 participants
Started: Jan 16, 2020 · Completed: Dec 12, 2025
4 conditions1 sponsor1 location
NCT04160858
Effects of Spinal Cord Injury Exercise Guidelines
NAActive, not recruiting
50 participants
Started: Jan 16, 2020 · Completed: Feb 14, 2025
2 conditions1 sponsor1 location
NCT04175600
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
PHASE3Active, not recruiting
138 participants
Started: Jan 16, 2020 · Completed: Oct 1, 2027
1 condition1 sponsor115 locations
NCT02923063
Exercise Study Testing Enhanced Energetics of Mitochondria Video Integrated Delivery of Activity Training in CKD
PHASE2Active, not recruiting
32 participants
Started: Jan 16, 2020 · Completed: Oct 2, 2025
2 conditions1 sponsor1 location
NCT04100161
Nutritional Strategies After Muscle Strain Injuries
NAActive, not recruiting
50 participants
Started: Jan 16, 2020 · Completed: Aug 1, 2029
1 condition3 sponsors1 location
NCT04227483
Deflazacort Vs. Prednisolone in Acute-stage ABPA
PHASE2/PHASE3Active, not recruiting
150 participants
Started: Jan 15, 2020 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT04078568
Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease
PHASE3Active, not recruiting
3,208 participants
Started: Jan 15, 2020 · Completed: Dec 31, 2025
1 condition15 sponsors34 locations
NCT05063760
Exercise in Testicular Germ Cell Cancer Survivors
NAActive, not recruiting
60 participants
Started: Jan 15, 2020 · Completed: Jun 30, 2024
1 condition2 sponsors2 locations
NCT03871257
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
PHASE3Active, not recruiting
165 participants
Started: Jan 15, 2020 · Completed: Dec 31, 2030
3 conditions1 sponsor132 locations
NCT04349839
ACRODAT Prospective Evaluation Study
N/AActive, not recruiting
500 participants
Started: Jan 15, 2020 · Completed: Feb 1, 2025
1 condition1 sponsor1 location
NCT04220034
Autoantibodies Prevalence During Checkpoint Inhibitor Treatment
N/AActive, not recruiting
150 participants
Started: Jan 15, 2020 · Completed: Dec 15, 2024
1 condition1 sponsor1 location
NCT04962919
Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.
N/AActive, not recruiting
584 participants
Started: Jan 14, 2020 · Completed: May 7, 2025
1 condition1 sponsor8 locations
NCT04200443
Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma
PHASE2Active, not recruiting
72 participants
Started: Jan 14, 2020 · Completed: Oct 7, 2025
11 conditions2 sponsors5 locations
NCT02984566
Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)
NAActive, not recruiting
32 participants
Started: Jan 14, 2020 · Completed: Jan 31, 2026
1 condition1 sponsor4 locations
NCT05003414
The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study
N/AActive, not recruiting
200 participants
Started: Jan 14, 2020 · Completed: Dec 31, 2032
5 conditions1 sponsor5 locations
NCT03960476
Decision Making and Implementation of Aging-in-Place/Long Term Care Plans Among Older Adults
NAActive, not recruiting
293 participants
Started: Jan 13, 2020 · Completed: Feb 28, 2026
2 conditions2 sponsors1 location
NCT04150900
1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck
PHASE2Active, not recruiting
7 participants
Started: Jan 13, 2020 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT03831256
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood
NAActive, not recruiting
7,849 participants
Started: Jan 13, 2020 · Completed: Jun 30, 2025
2 conditions13 sponsors6 locations
NCT03651973
Prevention of Sequelae Pain After Breast Cancer Surgery by Self-massages and Self Stretching. Impact of Learning Workshops.
NAActive, not recruiting
143 participants
Started: Jan 13, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04452357
Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer
NAActive, not recruiting
12 participants
Started: Jan 13, 2020 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT04259970
Hyperpolarized Imaging for New Treatments
PHASE4Active, not recruiting
64 participants
Started: Jan 13, 2020 · Completed: Dec 31, 2025
1 condition4 sponsors4 locations
NCT04166487
Plasma-Adapted First-Line Pembro In NSCLC
PHASE2Active, not recruiting
40 participants
Started: Jan 13, 2020 · Completed: Dec 1, 2025
2 conditions2 sponsors5 locations
NCT04159779
A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece
N/AActive, not recruiting
180 participants
Started: Jan 13, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor21 locations
NCT04762108
Paediatric Sjögren Syndrome Cohort Study and Repository (PaedSSCoRe)
N/AActive, not recruiting
300 participants
Started: Jan 11, 2020 · Completed: Jan 10, 2030
1 condition8 sponsors8 locations
NCT04288531
Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region
N/AActive, not recruiting
304 participants
Started: Jan 10, 2020 · Completed: Jan 10, 2026
6 conditions5 sponsors10 locations
NCT04251091
Ankle Exosuit Training in the Clinic to Community Community
NAActive, not recruiting
10 participants
Started: Jan 10, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04267796
Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women
NAActive, not recruiting
50 participants
Started: Jan 10, 2020 · Completed: Jul 1, 2026
1 condition3 sponsors1 location
NCT04239820
Effect of Cladribine Treatment on Microglial Activation in the CNS
N/AActive, not recruiting
15 participants
Started: Jan 10, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04083378
Software-Aided Imaging (Morfeus) for Confirming Tumor Coverage With Ablation in Patients With Liver Tumors, the COVER-ALL Study
PHASE3Active, not recruiting
107 participants
Started: Jan 10, 2020 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT04113018
Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
PHASE2Active, not recruiting
39 participants
Started: Jan 10, 2020 · Completed: Oct 31, 2027
1 condition4 sponsors1 location
NCT04089059
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
NAActive, not recruiting
738 participants
Started: Jan 10, 2020 · Completed: Apr 30, 2028
1 condition1 sponsor74 locations
NCT04186650
Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts
PHASE1/PHASE2Active, not recruiting
3 participants
Started: Jan 10, 2020 · Completed: Jun 9, 2027
1 condition1 sponsor1 location
NCT04220021
Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD
PHASE2Active, not recruiting
38 participants
Started: Jan 10, 2020 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT04129502
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
PHASE3Active, not recruiting
354 participants
Started: Jan 10, 2020 · Completed: Oct 31, 2026
1 condition1 sponsor134 locations
NCT04088864
CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies
PHASE1Active, not recruiting
10 participants
Started: Jan 10, 2020 · Completed: Sep 10, 2036
3 conditions1 sponsor1 location
NCT04009967
Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning
PHASE2Active, not recruiting
30 participants
Started: Jan 10, 2020 · Completed: Mar 30, 2025
1 condition2 sponsors1 location
NCT04634617
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
N/AActive, not recruiting
310 participants
Started: Jan 9, 2020 · Completed: Apr 11, 2027
4 conditions2 sponsors1 location
NCT04173988
Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
EARLY_PHASE1Active, not recruiting
6 participants
Started: Jan 9, 2020 · Completed: Jul 20, 2025
1 condition1 sponsor1 location
NCT04075266
A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis
PHASE2Active, not recruiting
23 participants
Started: Jan 9, 2020 · Completed: Dec 1, 2029
1 condition1 sponsor12 locations
NCT04612465
Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula
PHASE3Active, not recruiting
46 participants
Started: Jan 9, 2020 · Completed: Sep 23, 2025
1 condition1 sponsor4 locations
NCT03901807
Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study
NAActive, not recruiting
150 participants
Started: Jan 9, 2020 · Completed: Apr 30, 2026
2 conditions1 sponsor20 locations
NCT04181203
Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy
PHASE3Active, not recruiting
490 participants
Started: Jan 9, 2020 · Completed: Dec 28, 2033
1 condition2 sponsors15 locations
NCT03972488
Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET
PHASE3Active, not recruiting
226 participants
Started: Jan 8, 2020 · Completed: Oct 29, 2027
1 condition1 sponsor40 locations
NCT03971799
Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia
PHASE1/PHASE2Active, not recruiting
52 participants
Started: Jan 8, 2020 · Completed: Dec 31, 2039
1 condition3 sponsors6 locations
NCT03945773
Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors
PHASE2Active, not recruiting
127 participants
Started: Jan 8, 2020 · Completed: Dec 30, 2030
1 condition1 sponsor40 locations
NCT05011799
The Peer Genetic Study
NAActive, not recruiting
149 participants
Started: Jan 8, 2020 · Completed: Sep 28, 2024
2 conditions2 sponsors1 location
NCT03759678
N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)
PHASE2Active, not recruiting
39 participants
Started: Jan 8, 2020 · Completed: Jul 1, 2025
2 conditions1 sponsor5 locations
NCT04024696
A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients
PHASE1/PHASE2Active, not recruiting
12 participants
Started: Jan 8, 2020 · Completed: Nov 30, 2025
1 condition2 sponsors4 locations
NCT04201873
Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
PHASE1Active, not recruiting
40 participants
Started: Jan 8, 2020 · Completed: Aug 1, 2027
1 condition5 sponsors1 location